Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Recruiting

Nuvaira Lung DenervationEvaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Sponsor:

Nuvaira, Inc.

Code:

NCT07051707

Conditions

COPD

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Targeted Lung Denervation (TLD)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-08. This information was provided to ClinicalTrials.gov by Nuvaira, Inc. on 2026-02-27.